← Open Payments lookup

KATARZYNA SMITH: Open Payments

NPI 1750800215 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$935 in 46 payments from 17 companies in 2025. Trend: 2023 $142 · 2024 $0 · 2025 $935

Food & beverage: $935
CompanyPaymentsAmount
Novo Nordisk Inc12$217
Bayer Healthcare Pharmaceuticals Inc.6$108
Amgen Inc.5$105
Dexcom, Inc.3$80
ABBVIE INC.4$80
Mannkind Corporation3$66
Radius Health, Inc.3$52
Tandem Diabetes Care, Inc.1$35
Chiesi USA, Inc.1$28
Corcept Therapeutics1$25

Products named: Ozempic, Kerendia, Dexcom G6 Transmitter, Wegovy, AFREZZA, TEPEZZA, Tymlos, REPATHA.

Industry payments across MD — which companies pay providers there.